4,955
Views
2
CrossRef citations to date
0
Altmetric
Review

Pain Characteristics and Biomarkers in Treatment Approaches for Osteoarthritis Pain

&
Pages 59-73 | Received 08 Jul 2020, Accepted 15 Sep 2020, Published online: 30 Oct 2020

References

  • Kolasinski SL , NeogiT , HochbergMCet.al 2019 American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis. Rheumatol.72(2), 220–233 (2020).
  • Smith L , WittenauerR , AdenK , DutheyB. Osteoarthritis. In: Priority Medicines for Europe and the World 2013 Update.KaplanW, WirtzVJ, Mantel-TeeuwisseA, StolkP, DutheyB, LaingR ( Eds). WHO, Geneva, Switzerland, 126–128 (2013).
  • GBD 2016 Disease and Injury Incidence and Prevalence Collaborators . Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet390(10100), 1211–1259 (2017).
  • GBD 2016 Disease and Injury Incidence and Prevalence Collaborators . Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet388(10053), 1545–1602 (2016).
  • Callhoff J , AlbrechtK , RedekerIet.al Disease burden of patients with osteoarthritis: results of a cross-sectional survey linked to claims data. Arthritis Care Res. (Hoboken)72(2), 193–200 (2020).
  • Sparkes V , WhatlingGM , BiggsPet.al Comparison of gait, functional activities, and patient-reported outcome measures in patients with knee osteoarthritis and healthy adults using 3D motion analysis and activity monitoring: an exploratory case-control analysis. Orthop. Res. Rev.11, 129–140 (2019).
  • Abbott JH , UsiskinIM , WilsonR , HansenP , LosinaE. The quality-of-life burden of knee osteoarthritis in New Zealand adults: a model-based evaluation. PLoS One12(10), e0185676 (2017).
  • Bruyere O , CooperC , PelletierJPet.al A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis-From evidence-based medicine to the real-life setting. Semin. Arthritis Rheum.45(Suppl. 4), S3–11 (2016).
  • Bruyère O , HonvoG , VeroneseNet.al An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin. Arthritis Rheum.49(3), 337–350 (2019).
  • Bannuru RR , OsaniMC , VaysbrotEEet.al OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthr. Cartil.27(11), 1578–1589 (2019).
  • Clauw DJ , HassettAL. The role of centralised pain in osteoarthritis. Clin. Exp. Rheumatol.35, (Suppl. 107(5)), 79–84 (2017).
  • Dell’Isola A , AllanR , SmithSL , MarreirosSS , SteultjensM. Identification of clinical phenotypes in knee osteoarthritis: a systematic review of the literature. BMC Musculoskelet. Disord.17(1), 425 (2016).
  • Eitner A , HofmannGO , SchaibleHG. Mechanisms of osteoarthritic pain. Studies in humans and experimental models. Front. Mol. Neurosci.10, 349 (2017).
  • Thakur M , DickensonAH , BaronR. Osteoarthritis pain: nociceptive or neuropathic?Nat. Rev. Rheumatol.10(6), 374–380 (2014).
  • Schaible HG . Nociceptive neurons detect cytokines in arthritis. Arthritis Res. Ther.16(5), 470 (2014).
  • Miller RE , TranPB , ObeidatAMet.al The role of peripheral nociceptive neurons in the pathophysiology of osteoarthritis pain. Curr. Osteoporosis Rep.13(5), 318–326 (2015).
  • Hunter DJ , Bierma-ZeinstraS. Osteoarthritis. Lancet393(10182), 1745–1759 (2019).
  • Griffin TM , ScanzelloCR. Innate inflammation and synovial macrophages in osteoarthritis pathophysiology. Clin. Exp. Rheumatol.37(Suppl. 120(5)), 57–63 (2019).
  • Fingleton C , SmartK , MoloneyN , FullenBM , DoodyC. Pain sensitization in people with knee osteoarthritis: a systematic review and meta-analysis. Osteoarthr. Cartil.23(7), 1043–1056 (2015).
  • Syx D , TranPB , MillerRE , MalfaitAM. Peripheral mechanisms contributing to osteoarthritis pain. Curr. Rheumatol. Rep.20(2), 9 (2018).
  • Arendt-Nielsen L . Pain sensitisation in osteoarthritis. Clin. Exp. Rheumatol.35, (Suppl. 107[5]), 68–74 (2017).
  • Lluch E , TorresR , NijsJ , Van OosterwijckJ. Evidence for central sensitization in patients with osteoarthritis pain: a systematic literature review. Eur. J. Pain18(10), 1367–1375 (2014).
  • National Institute for Health and Care Excellence . Osteoarthritis overview 2020. https://pathways.nice.org.uk/pathways/osteoarthritis/osteoarthritis-overview.
  • Poulsen E , GoncalvesGH , BriccaA , RoosEM , ThorlundJB , JuhlCB. Knee osteoarthritis risk is increased 4–6 fold after knee injury - a systematic review and meta-analysis. Br. J. Sports Med.53(23), 1454–1463 (2019).
  • Gooberman-Hill R , WoolheadG , MackichanF , AyisS , WilliamsS , DieppeP. Assessing chronic joint pain: lessons from a focus group study. Arthritis Rheum.57(4), 666–671 (2007).
  • Gooberman-Hill R , FrenchM , DieppeP , HawkerG. Expressing pain and fatigue: a new method of analysis to explore differences in osteoarthritis experience. Arthritis Rheum.61(3), 353–360 (2009).
  • Hawker GA , StewartL , FrenchMRet.al Understanding the pain experience in hip and knee osteoarthritis – an OARSI/OMERACT initiative. Osteoarthr. Cartil.16(4), 415–422 (2008).
  • Alvarez-Soria MA , LargoR , SantillanaJet.al Long term NSAID treatment inhibits COX-2 synthesis in the knee synovial membrane of patients with osteoarthritis: differential proinflammatory cytokine profile between celecoxib and aceclofenac. Ann. Rheum. Dis.65(8), 998–1005 (2006).
  • Kolasinski SL , NeogiT , HochbergMCet.al 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Care Res. (Hoboken)72(2), 149–162 (2020).
  • Gignac MAM , IrvinE , CullenKet.al Men and women’s occupational activities and the risk of developing osteoarthritis of the knee, hip, or hands: a systematic review and recommendations for future research. Arthritis Care Res. (Hoboken)72(3), 378–396 (2020).
  • Felson DT . Developments in the clinical understanding of osteoarthritis. Arthritis Res. Ther.11(1), 203 (2009).
  • Ohtori S , OritaS , YamashitaMet.al Existence of a neuropathic pain component in patients with osteoarthritis of the knee. Yonsei Med. J.53(4), 801–805 (2012).
  • Attal N , CruccuG , BaronRet.al EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur. J. Neurol17(9), 1113–1111e1188 (2010).
  • Kellgren JH , LawrenceJS. Radiological assessment of osteo-arthrosis. Ann. Rheum. Dis16(4), 494–502 (1957).
  • Kohn MD , SassoonAA , FernandoND. Classifications in Brief: Kellgren-Lawrence classification of osteoarthritis. Clin. Orthop. Relat. Res.474(8), 1886–1893 (2016).
  • Bedson J , CroftPR. The discordance between clinical and radiographic knee osteoarthritis: a systematic search and summary of the literature. BMC Musculoskelet. Disord.9, 116 (2008).
  • Melzack R . The McGill Pain Questionnaire: major properties and scoring methods. Pain1(3), 277–299 (1975).
  • Melzack R . The short-form McGill Pain Questionnaire. Pain30(2), 191–197 (1987).
  • De Oliveira Paes Leme M , YuanSLK , OliveiraMagalhães M , Ferreirade Meneses SR , MarquesAP. Pain and quality of life in knee osteoarthritis, chronic low back pain and fibromyalgia: a comparative cross-sectional study. Reumatismo71(2), 68–74 (2019).
  • Cedraschi C , DelézayS , MartyMet.al “Let’s talk about OA pain”: a qualitative analysis of the perceptions of people suffering from OA. Towards the development of a specific pain OA-Related questionnaire, the Osteoarthritis Symptom Inventory Scale (OASIS). PLoS One8(11), e79988 (2013).
  • Murphy SL , LydenAK , KratzALet.al Characterizing pain flares from the perspective of individuals with symptomatic knee osteoarthritis. Arthritis Care Res. (Hoboken)67(8), 1103–1111 (2015).
  • Marques AP , RhodenL , deOliveira Siqueira J , JoãoSM. Pain evaluation of patients with fibromyalgia, osteoarthritis, and low back pain. Rev. Hosp. Clin. Fac. Med. Sao Paulo56(1), 5–10 (2001).
  • Hochman JR , FrenchMR , BerminghamSL , HawkerGA. The nerve of osteoarthritis pain. Arthritis Care Res. (Hoboken)62(7), 1019–1023 (2010).
  • de Rooij M , vander Leeden M , HeymansMWet.al Prognosis of pain and physical functioning in patients with knee osteoarthritis: a systematic review and meta-analysis. Arthritis Care Res. (Hoboken)68(4), 481–492 (2016).
  • de Rooij M , vander Leeden M , HeymansMWet.al Course and predictors of pain and physical functioning in patients with hip osteoarthritis: Systematic review and meta-analysis. J. Rehabil. Med.48(3), 245–252 (2016).
  • Thudium CS , LofvallH , KarsdalMA , Bay-JensenAC , BihletAR. Protein biomarkers associated with pain mechanisms in osteoarthritis. J. Proteomics190, 55–66 (2019).
  • Arendt-Nielsen L , NieH , LaursenMBet.al Sensitization in patients with painful knee osteoarthritis. Pain149(3), 573–581 (2010).
  • Treede RD , RiefW , BarkeAet.al A classification of chronic pain for ICD-11. Pain156(6), 1003–1007 (2015).
  • Neville SJ , ClauwAD , MoserSEet.al Association between the 2011 fibromyalgia survey criteria and multisite pain sensitivity in knee osteoarthritis. Clin. J. Pain34(10), 909–917 (2018).
  • French HP , SmartKM , DoyleF. Prevalence of neuropathic pain in knee or hip osteoarthritis: A systematic review and meta-analysis. Semin. Arthritis Rheum.47(1), 1–8 (2017).
  • International Association for the Study of Pain . IASP terminology. International Association for the Study of Pain, 2018. https://www.iasp-pain.org/Education/Content.aspx?ItemNumber=1698
  • Trouvin AP , PerrotS. New concepts of pain. Best Pract. Res. Clin. Rheumatol.33(3), 101415 (2019).
  • Miller RE , TranPB , IshiharaSet.al Microarray analyses of the dorsal root ganglia support a role for innate neuro-immune pathways in persistent pain in experimental osteoarthritis. Osteoarthr. Cartil.28(5), 581–592 (2020).
  • Richter F , NaturaG , LoserS , SchmidtK , ViisanenH , SchaibleHG. Tumor necrosis factor causes persistent sensitization of joint nociceptors to mechanical stimuli in rats. Arthritis Rheum.62(12), 3806–3814 (2010).
  • Konig C , MorchE , EitnerAet.al Involvement of spinal IL-6 trans-signaling in the induction of hyperexcitability of deep dorsal horn neurons by spinal tumor necrosis factor-alpha. J. Neurosci.36(38), 9782–9791 (2016).
  • Leung YY , HuebnerJL , HaalandB , WongSBS , KrausVB. Synovial fluid pro-inflammatory profile differs according to the characteristics of knee pain. Osteoarthr. Cartil.25(9), 1420–1427 (2017).
  • Garnero P , MazieresB , GueguenAet.al Cross-sectional association of 10 molecular markers of bone, cartilage, and synovium with disease activity and radiological joint damage in patients with hip osteoarthritis: the ECHODIAH cohort. J. Rheumatol.32(4), 697–703 (2005).
  • Nees TA , RosshirtN , ZhangJAet.al Synovial cytokines significantly correlate with osteoarthritis-related knee pain and disability: inflammatory mediators of potential clinical relevance. J. Clin. Med.8(9), 1343 (2019).
  • Ren G , LutzI , RailtonPet.al Serum and synovial fluid cytokine profiling in hip osteoarthritis: distinct from knee osteoarthritis and correlated with pain. BMC Musculoskelet. Disord.19(1), 39 (2018).
  • Ruan G , XuJ , WangKet.al Associations between serum IL-8 and knee symptoms, joint structures, and cartilage or bone biomarkers in patients with knee osteoarthritis. Clin. Rheumatol.38(12), 3609–3617 (2019).
  • Li L , LiZ , LiY , HuX , ZhangY , FanP. Profiling of inflammatory mediators in the synovial fluid related to pain in knee osteoarthritis. BMC Musculoskelet. Disord.21(1), 99 (2020).
  • Haraden CA , HuebnerJL , HsuehMF , LiYJ , KrausVB. Synovial fluid biomarkers associated with osteoarthritis severity reflect macrophage and neutrophil related inflammation. Arthritis Res. Ther.21(1), 146 (2019).
  • Ke X , JinG , YangYet.al Synovial fluid HMGB-1 levels are associated with osteoarthritis severity. Clin. Lab.61(7), 809–818 (2015).
  • Wang C , GongZ , HuS , ZhangG. Metallothionein-1 is associated with osteoarthritis disease activity and suppresses proinflammatory cytokines production in synovial cells. Int. Immunopharmacol.75, 105815 (2019).
  • Zhang PL , LiuJ , XuL , SunY , SunXC. Synovial fluid macrophage migration inhibitory factor levels correlate with severity of self-reported pain in knee osteoarthritis patients. Med. Sci. Monit.22, 2182–2186 (2016).
  • Sowers MF , Karvonen-GutierrezCA , YosefMet.al Longitudinal changes of serum COMP and urinary CTX-II predict X-ray defined knee osteoarthritis severity and stiffness in women. Osteoarthr. Cartil.17(12), 1609–1614 (2009).
  • Bihlet AR , ByrjalsenI , Bay-JensenACet.al Associations between biomarkers of bone and cartilage turnover, gender, pain categories and radiographic severity in knee osteoarthritis. Arthritis Res. Ther.21(1), 203 (2019).
  • Kapetanakis S , DrygiannakisI , KazakosKet.al Serum TGF-beta2 and TGF-beta3 are increased and positively correlated to pain, functionality, and radiographic staging in osteoarthritis. Orthopedics33(8), (2010).
  • Attur M , StatnikovA , SamuelsJet.al Plasma levels of interleukin-1 receptor antagonist (IL1Ra) predict radiographic progression of symptomatic knee osteoarthritis. Osteoarthr. Cartil.23(11), 1915–1924 (2015).
  • Sachdeva M , AggarwalA , SharmaRet.al Chronic inflammation during osteoarthritis is associated with an increased expression of CD161 during advanced stage. Scand. J. Immunol.90(1), e12770 (2019).
  • Tang Q , HuZC , ShenLY , ShangP , XuHZ , LiuHX. Association of osteoarthritis and circulating adiponectin levels: a systematic review and meta-analysis. Lipids Health Dis.17(1), 189 (2018).
  • Daghestani HN , PieperCF , KrausVB. Soluble macrophage biomarkers indicate inflammatory phenotypes in patients with knee osteoarthritis. Arthritis Rheumatol. (Hoboken, N.J.)67(4), 956–965 (2015).
  • Valdes AM , MeulenbeltI , ChassaingEet.al Large scale meta-analysis of urinary C-terminal telopeptide, serum cartilage oligomeric protein and matrix metalloprotease degraded type II collagen and their role in prevalence, incidence and progression of osteoarthritis. Osteoarthr. Cartil.22(5), 683–689 (2014).
  • Kraus VB , CollinsJE , HargroveDet.al Predictive validity of biochemical biomarkers in knee osteoarthritis: data from the FNIH OA Biomarkers Consortium. Ann. Rheum. Dis.76(1), 186–195 (2017).
  • Arendt-Nielsen L , EskehaveTN , EgsgaardLLet.al Association between experimental pain biomarkers and serologic markers in patients with different degrees of painful knee osteoarthritis. Arthritis Rheumatol. (Hoboken, N.J.)66(12), 3317–3326 (2014).
  • Deitos A , Dussan-SarriaJA , SouzaAet.al Clinical value of serum neuroplasticity mediators in identifying the central sensitivity syndrome in patients with chronic pain with and without structural pathology. Clin. J. Pain31(11), 959–967 (2015).
  • Benito MJ , VealeDJ , FitzGeraldO , vanden Berg WB , BresnihanB. Synovial tissue inflammation in early and late osteoarthritis. Ann. Rheum. Dis.64(9), 1263–1267 (2005).
  • Namer B , SchickM , KleggetveitIPet.al Differential sensitization of silent nociceptors to low pH stimulation by prostaglandin E2 in human volunteers. Eur. J. Pain19(2), 159–166 (2015).
  • Khasabova IA , UhelskiM , KhasabovSG , GuptaK , SeyboldVS , SimoneDA. Sensitization of nociceptors by prostaglandin E(2)-glycerol contributes to hyperalgesia in mice with sickle cell disease. Blood133(18), 1989–1998 (2019).
  • Bathina S , DasUN. Brain-derived neurotrophic factor and its clinical implications. Arch. Med. Sci.11(6), 1164–1178 (2015).
  • Lima Giacobbo B , DoorduinJ , KleinHC , DierckxR , BrombergE , de VriesEFJ. Brain-derived neurotrophic factor in brain disorders: focus on neuroinflammation. Mol. Neurobiol.56(5), 3295–3312 (2019).
  • Gourlay DL , HeitHA. Pain and addiction: managing risk through comprehensive care. J. Addict. Dis27(3), 23–30 (2008).
  • Perrot S , CohenM , BarkeA , KorwisiB , RiefW , TreedeRD. The IASP classification of chronic pain for ICD-11: chronic secondary musculoskeletal pain. Pain160(1), 77–82 (2019).
  • Deng ZH , ZengC , YangYet.al Topical diclofenac therapy for osteoarthritis: a meta-analysis of randomized controlled trials. Clin. Rheumatol.35(5), 1253–1261 (2016).
  • Persson MSM , StocksJ , WalshDA , DohertyM , ZhangW. The relative efficacy of topical non-steroidal anti-inflammatory drugs and capsaicin in osteoarthritis: a network meta-analysis of randomised controlled trials. Osteoarthr. Cartil.26(12), 1575–1582 (2018).
  • Zeng C , WeiJ , PerssonMSMet.al Relative efficacy and safety of topical non-steroidal anti-inflammatory drugs for osteoarthritis: a systematic review and network meta-analysis of randomised controlled trials and observational studies. Br. J. Sports Med.52(10), 642–650 (2018).
  • Wiffen PJ , XiaJ. Systematic review of topical diclofenac for the treatment of acute and chronic musculoskeletal pain. Curr. Med. Res. Opin. accepted, 1 (2020).
  • van Walsem A , PandhiS , NixonRM , GuyotP , KarabisA , MooreRA. Relative benefit-risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis: a network meta-analysis. Arthritis Res. Ther.17, 66 (2015).
  • da Costa BR , ReichenbachS , KellerNet.al Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. Lancet390(10090), E21–E33 (2017).
  • Puljak L , MarinA , VrdoljakD , MarkoticF , UtrobicicA , TugwellP. Celecoxib for osteoarthritis. Cochrane Database Syst. Rev.5, Cd009865 (2017).
  • Citrome L , Weiss-CitromeA. A systematic review of duloxetine for osteoarthritic pain: what is the number needed to treat, number needed to harm, and likelihood to be helped or harmed?Postgrad. Med.124(1), 83–93 (2012).
  • Toupin April K , BisaillonJ , WelchVet.al Tramadol for osteoarthritis. Cochrane Database Syst Rev5, Cd005522 (2019).
  • Jüni P , HariR , RutjesAWet.al Intra-articular corticosteroid for knee osteoarthritis. Cochrane Database Syst Rev (10), CD005328 (2015).
  • Cohen J . The analysis of variance. In: Statistical Power Analysis for the Behavioral Sciences.CohenJ ( Ed.). Lawrence Erlbaum Associates, NJ, USA, 273–406 (1988).
  • Mason L , MooreRA , EdwardsJE , DerryS , McQuayHJ. Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis. BMC. Musculoskelet. Disord5, 28 (2004).
  • Baer PA , ThomasLM , ShainhouseZ. Treatment of osteoarthritis of the knee with a topical diclofenac solution: a randomised controlled, 6-week trial [ISRCTN53366886]. BMC Musculoskelet. Disord.6, 44 (2005).
  • Osiri M , Suarez-AlmazorME , WellsGA , RobinsonV , TugwellP. Number needed to treat (NNT): implication in rheumatology clinical practice. Ann. Rheum. Dis.62(4), 316–321 (2003).
  • Hagen M , BakerM. Skin penetration and tissue permeation after topical administration of diclofenac. Curr. Med. Res. Opin.33(9), 1623–1634 (2017).
  • Chlud K , WagenerHH. Percutaneous non-steroidal anti-inflammatory drug (NSAID) therapy with particular reference to pharmacokinetic factors. Eular Bull.2, 40–43 (1987).
  • Zweers MC , de BoerTN , van RoonJ , BijlsmaJW , LafeberFP , MastbergenSC. Celecoxib: considerations regarding its potential disease-modifying properties in osteoarthritis. Arthritis Res. Ther.13(5), 239 (2011).
  • Nakata K , HanaiT , TakeYet.al Disease-modifying effects of COX-2 selective inhibitors and non-selective NSAIDs in osteoarthritis: a systematic review. Osteoarthr. Cartil.26(10), 1263–1273 (2018).
  • Niibori M , KudoY , HayakawaTet.al Mechanism of aspirin-induced inhibition on the secondary hyperalgesia in osteoarthritis model rats. Heliyon6(5), e03963 (2020).
  • Park JW , YunYP , ParkKet.al Ibuprofen-loaded porous microspheres suppressed the progression of monosodium iodoacetate-induced osteoarthritis in a rat model. Colloids Surf. B. Biointerfaces147, 265–273 (2016).
  • Zhang SL , LiuHQ , XuXZ , ZhiJ , GengJJ , ChenJ. Effects of exercise therapy on knee joint function and synovial fluid cytokine levels in patients with knee osteoarthritis. Mol Med Rep7(1), 183–186 (2013).
  • Hussain SA , JassimNA , NumanIT , AlK , AbdullahTAII. Anti-inflammatory activity of silymarin in patients with knee osteoarthritis. A comparative study with piroxicam and meloxicam. Saudi Med. J.30(1), 98–103 (2009).
  • Gineyts E , MoJA , KoAet.al Effects of ibuprofen on molecular markers of cartilage and synovium turnover in patients with knee osteoarthritis. Ann. Rheum. Dis.63(7), 857–861 (2004).
  • Konstantinidis I , PapageorgiouSN , KyrgidisA , TzellosTG , KouvelasD. Effect of non-steroidal anti-inflammatory drugs on bone turnover: an evidence-based review. Rev. Recent Clin. Trials8(1), 48–60 (2013).
  • Manicourt DH , BevilacquaM , RighiniV , FamaeyJP , DevogelaerJP. Comparative effect of nimesulide and ibuprofen on the urinary levels of collagen type II C-telopeptide degradation products and on the serum levels of hyaluronan and matrix metalloproteinases-3 and -13 in patients with flare-up of osteoarthritis. Drugs in R&D6(5), 261–271 (2005).
  • Bianchi M , BrogginiM , BalzariniP , FranchiS , SacerdoteP. Effects of nimesulide on pain and on synovial fluid concentrations of substance P, interleukin-6 and interleukin-8 in patients with knee osteoarthritis: comparison with celecoxib. Int. J. Clin. Pract.61(8), 1270–1277 (2007).
  • Pelletier JP , RaynauldJP , CaronJet.al Decrease in serum level of matrix metalloproteinases is predictive of the disease-modifying effect of osteoarthritis drugs assessed by quantitative MRI in patients with knee osteoarthritis. Ann. Rheum. Dis.69(12), 2095–2101 (2010).
  • Gallelli L , GalassoO , FalconeDet.al The effects of nonsteroidal anti-inflammatory drugs on clinical outcomes, synovial fluid cytokine concentration and signal transduction pathways in knee osteoarthritis. A randomized open label trial. Osteoarthr. Cartil.21(9), 1400–1408 (2013).
  • Hess A , AxmannR , RechJet.al Blockade of TNF-alpha rapidly inhibits pain responses in the central nervous system. Proc. Natl Acad. Sci. USA108(9), 3731–3736 (2011).
  • Persson MSM , SarmanovaA , DohertyM , ZhangW. Conventional and biologic disease-modifying anti-rheumatic drugs for osteoarthritis: a meta-analysis of randomized controlled trials. Rheumatology (Oxford)57(10), 1830–1837 (2018).
  • Moore RA , ChiCC , WiffenPJ , DerryS , RiceAS. Oral nonsteroidal anti-inflammatory drugs for neuropathic pain. Cochrane Database Syst Rev (10), Cd010902 (2015).
  • Wang ZY , ShiSY , LiSJet.al Efficacy and safety of duloxetine on osteoarthritis knee pain: a meta-analysis of randomized controlled trials. Pain Med.16(7), 1373–1385 (2015).
  • Osani MC , BannuruRR. Efficacy and safety of duloxetine in osteoarthritis: a systematic review and meta-analysis. Korean J. Intern. Med.34(5), 966–973 (2019).
  • Lunn MP , HughesRA , WiffenPJ. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst Rev (1), Cd007115 (2014).
  • Watt FE . Osteoarthritis biomarkers: year in review. Osteoarth. Cartil.26(3), 312–318 (2018).
  • Gundogdu G , GundogduK , MilogluFD , TascıSY. A new perspective on the relation between obesity and knee osteoarthritis: omentin. Curr. Rheumatol. Rev. (2019) ( Epub ahead of print) DOI: 10.2174/1573397116666191226122801.
  • Poonpet T , HonsawekS. Adipokines: Biomarkers for osteoarthritis?World J. Orthopedics5(3), 319–327 (2014).
  • Mosquera A , Rego-PérezI , BlancoFJ , FernándezJL. Leukocyte telomere length in patients with radiographic knee osteoarthritis. Environ. Mol. Mutagen.60(3), 298–301 (2019).
  • Griswold AJ , PerezJ , NuytemansKet.al Transcriptomic analysis of synovial extracellular RNA following knee trauma: a pilot study. J. Orthop. Res.36(6), 1659–1665 (2018).
  • Catterall JB , StablerTV , FlanneryCR , KrausVB. Changes in serum and synovial fluid biomarkers after acute injury (NCT00332254). Arthritis Res. Ther.12(6), R229 (2010).